VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma
NCT07028086
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Myeloid Sarcoma
Interventions
DRUG:
VAM_GROUP
Sponsor
Ruijin Hospital